Malaysian Genomics collaborate on cannabinoid R&D

KUALA LUMPUR: The Malaysian Genomics Resource Centre Bhd (MGRC) has entered into a strategic collaboration with Kensana Health Canada and MAHSA University for the research and development (R&D) of phytopharmaceutical and biotechnology products that can lead to commercialisation.

MGRC, a genomics and biopharmaceutical specialist company, said in a statement today that the collaboration involves joint R&D on species improvement, identification, formulation and pre-clinical testing of novel phytocompounds with potential therapeutic and commercial value.